РЫБИЙ ЖИР ПРОТИВ … ЖИРА

Ежедневное потребление 700–1620 мг DHA снижает жировые отложения, включая жир на животе, у людей с диабетом. Рыбий жир также уменьшает воспаление, связанное с ожирением.

Избыток жира в организме увеличивает выработку воспалительных цитокинов, в том числе интерлейкина 1 бета (ИЛ-1 бета), интерлейкина 6 (ИЛ-6), и фактор некроза опухоли-альфа (TNF-альфа).

И еще целый список полезностей омега-3:

1. Available at: www.nhlbi.nih.gov/health/health-topics/topics/ms. Accessed February 27, 2020.
2. Hirode G, Wong RJ. Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016. JAMA. 2020 Jun 23;323(24):2526-8.
3. Available at: www.uptodate.com/contents/metabolic-syndrome-insulin-resistance-syndrome-or-syndrome-x. Accessed February 15, 2021.
4. Lima-Fontes M, Barata P, Falcao M, et al. Ocular findings in metabolic syndrome: a review. Porto Biomed J. 2020 Nov-Dec;5(6):e104.
5. Nilsson PM, Tuomilehto J, Ryden L. The metabolic syndrome — What is it and how should it be managed? Eur J Prev Cardiol. 2019 Dec;26(2_suppl):33-46.
6. Nolan CJ, Prentki M. Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. Diab Vasc Dis Res. 2019 Mar;16(2):118-27.
7. Aguilar-Salinas CA, Viveros-Ruiz T. Recent advances in managing/understanding the metabolic syndrome. F1000Res. 2019;8.
8. Souza DR, Pieri B, Comim VH, et al. Fish oil reduces subclinical inflammation, insulin resistance, and atherogenic factors in overweight/obese type 2 diabetes mellitus patients: A pre-post pilot study. J Diabetes Complications. 2020 May;34(5):107553.
9. Gao H, Geng T, Huang T, et al. Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis. Lipids Health Dis. 2017 Jul 3;16(1):131.
10. Serhiyenko V. Omega-3 Polyunsaturated Fatty Acids, Metabolic Syndrome and Diabetes Mellitus. Current Research in Diabetes & Obesity Journal. 2018 02/06;5(4).
11. Srigley CT, Rader JI. Content and composition of fatty acids in marine oil omega-3 supplements. J Agric Food Chem. 2014 Jul 23;62(29):7268-78.
12. Papanikolaou Y, Brooks J, Reider C, et al. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from NHANES 2003-2008. Nutr J. 2014 Apr 2;13:31.
13. Rochlani Y, Pothineni NV, Kovelamudi S, et al. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017 Aug;11(8):215-25.
14. de Camargo Talon L, de Oliveira EP, Moreto F, et al. Omega-3 fatty acids supplementation decreases metabolic syndrome prevalence after lifestyle modification program. Journal of Functional Foods. 2015 02/01;19:922-8.
15. Mansoori A, Sotoudeh G, Djalali M, et al. Docosahexaenoic Acid-Rich Fish Oil Supplementation Improves Body Composition without Influence of the PPARgamma Pro12Ala Polymorphism in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J Nutrigenet Nutrigenomics. 2015;8(4-6): 195-204.
16. Doyle R, Sadlier DM, Godson C. Pro-resolving lipid mediators: Agents of anti-ageing? Semin Immunol. 2018 Dec;40:36-48.
17. Colussi G, Catena C, Fagotto V, et al. Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of omega-3 polyunsaturated fatty acids. Crit Rev Food Sci Nutr. 2019 Jan 30;59(12):1937-48.
18. Polus A, Zapala B, Razny U, et al. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production. Biochim Biophys Acta. 2016 Nov;1861(11):1746-55.
19. Kwon Y. Immuno-Resolving Ability of Resolvins, Protectins, and Maresins Derived from Omega-3 Fatty Acids in Metabolic Syndrome. Mol Nutr Food Res. 2020 Feb;64(4):e1900824.
20. Delpino FM, Figueiredo LM, da Silva BGC, et al. Omega-3 supplementation and diabetes: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2021 Jan 22:1-14.
21. Abbott KA, Burrows TL, Acharya S, et al. DHA-enriched fish oil reduces insulin resistance in overweight and obese adults. Prostaglandins Leukot Essent Fatty Acids. 2020 Aug;159:102154.
22. Wolska A, Yang ZH, Remaley AT. Hypertriglyceridemia: new approaches in management and treatment. Curr Opin Lipidol. 2020 Dec;31(6):331-9.
23. Bernasconi AA, Wiest MM, Lavie CJ, et al. Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials. Mayo Clin Proc. 2021 Feb;96(2):304-13.
24. Thota RN, Acharya SH, Garg ML. Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial. Lipids Health Dis. 2019 Jan 26;18(1):31.
25. Xyda SE, Vuckovic I, Petterson XM, et al. Distinct Influence of Omega-3 Fatty Acids on the Plasma Metabolome of Healthy Older Adults. J Gerontol A Biol Sci Med Sci. 2020 Apr 17;75(5): 875-84.
26. Available at: www.fda.gov/food/cfsan-constituent-updates/fda-announces-new-qualified-health-claims-epa-and-dha-omega-3-consumption-and-risk-hypertension-and. Accessed February 22, 2021.
27. da Silva AA, do Carmo JM, Li X, et al. Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited. Can J Cardiol. 2020 May;36(5):671-82.
28. Zheng C, Liu Z. Vascular function, insulin action, and exercise: an intricate interplay. Trends Endocrinol Metab. 2015 Jun;26(6): 297-304.
29. Jahn LA, Hartline L, Rao N, et al. Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic Syndrome Subjects. J Clin Endocrinol Metab. 2016 Mar;101(3):1198-206.
30. Colussi G, Catena C, Novello M, et al. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes. Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):191-200.
31. DiNicolantonio JJ, J OK. Importance of maintaining a low omega-6/omega-3 ratio for reducing platelet aggregation, coagulation and thrombosis. Open Heart. 2019;6(1):e001011.
32. Elagizi A, Lavie CJ, O’Keefe E, et al. An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health. Nutrients. 2021 Jan 12;13(1):204.

#терапия_сахарного_диабета_1_типа

#лечение_сахарного_диабета_1_типа_у_детей

#клеточная_терапия_стволовыми_клетками_сахарного_диабета_1_типа

#иммунотерапия_сахарного_диабета_1_типа

#генная_терапия_ex_vivo_сахарного_диабета_1_типа

#комбинированная_терапия_сахарного_диабета_1_типа_теплизумаб

#иммуносупрессия_при_сахарном_диабета_1_типа_ абатацепт

#инсулин

#отмена_инсулинотерапии

#мезенхимальные_стволовые_клетки_сахарный_диабет_1_типа

#гемопоэтические_стволовые_клетки_сахарный_диабет_1_типа

#излечение_сахарного_диабета_1_типа

#новые_методы_терапии_сахарного_диабета_1_типа

#Канадский_институт_регенеративной_медицины_Торонто_Онтарио

#Профессор_кафедры_экспериментальных_методов_терапии_Юрий_Захаров

#глюкометр

Акучек

#Либра

#Образ_жизни_при_сахарном_диабете_1_типа

#Питание_при_сахарном_диабете_1_типа

#Особенности_физической_нагрузки_двигательной_активности_при_сахарном_диабете_1_типа

#фитотерапия_сахарного_диабета_1_типа

#акупунктура_иглоукалывание_рефлексотерапия_при сахарном_диабете_1_типа

#нутрицевтики_БАД_при сахарном_диабете_1_типа